AGAPPE DIAGNOSTICS LTD

Ernakulam-based Agappe Diagnostics Limited gathered a revenue of Rs 273 crore during the FY20-21 exhibiting a growth of 35 per cent with respect to the revenue generation of Rs 203 crore during the FY 19-20. The company developed Agappe Chitra Magna, a magnetic nanoparticle-based RNA extraction kit in collaboration with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in Trivandrum. Cyient entered into a manufacturing partnership with Agappe for the marketing of Mispa Count X, an indigenously designed and developed three-part hematology analyser. The company also launched India’s fastest COVID-19 confirmatory test solution without RNA extraction step, on RT-LAMP platform.